Vellaparambil Sudhakaran Ananthakrishnan
About Vellaparambil Sudhakaran Ananthakrishnan
Vellaparambil Sudhakaran Ananthakrishnan has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Miraiio Private Limited and Atmeva Herbals Llp. Formerly with 1 company, such as Causematch India Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Miraiio Private Limited
U62013KL2023PTC085409
|
Director | 30 Dec 2023 | 2023 | Active |
Atmeva Herbals Llp
ACC-2796
|
Designated Partner | 28 Jul 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Causematch India Private Limited
U74999KL2017PTC048827
|
Director | 10 Apr 2017 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vellaparambil Sudhakaran Ananthakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vellaparambil Sudhakaran Ananthakrishnan
Vellaparambil Sudhakaran Ananthakrishnan has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Miraiio Private Limited and Atmeva Herbals Llp. Formerly with 1 company, such as Causematch India Private Limited. Engaged in General Business. Contributes to corporate operations.
Vellaparambil Sudhakaran Ananthakrishnan is associated with 2 companies as Director and Designated Partner.
Vellaparambil Sudhakaran Ananthakrishnan has expertise in General Business.
Vellaparambil Sudhakaran Ananthakrishnan has 9 years in corporate governance.